Skip to main content
    T

    Travere Therapeutics Inc (TVTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $51.10
    +1.40 (+2.82%)

    Market Cap: $4.86B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Travere Therapeutics Inc (TVTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Travere Therapeutics (TVTX) has a latest price of $51.10 on Nov 17, 2026, 25.7% below its 52-week high of $68.73. Its price rose 48.1% over the past 12 months. The month-end price rose 167.3% over the 10 years through Oct 2026, a compound annual rate of 10.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $66.28 in Aug 2026 and its lowest $5.53 in Apr 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TVTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TVTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 22.5%, and over 6 months it rose 20.9%. The month-end price rose 677.6% over the 3 years through Oct 2026, a compound annual rate of 98.1%.

    PeriodChange
    1 month+1.2%
    3 months-22.5%
    6 months+20.9%
    12 months+48.1%
    12 months, with dividends+48.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+677.6%+98.1%
    5 years+74.9%+11.8%
    10 years+167.3%+10.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 119.3%, and its weakest was 2023, when it fell 57.3%.

    YearCloseChange
    2026 through Oct 2026$50.39+31.9%
    2025$38.21+119.3%
    2024$17.42+93.8%
    2023$8.99-57.3%
    2022$21.03-32.2%
    2021$31.04+13.9%
    2020$27.25+91.9%
    2019$14.20-37.3%
    2018$22.63+7.4%
    2017$21.07+11.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.6% below its 50-day average of $55.32 and 6.8% above its 200-day average of $47.87.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$51.10
    52-week high$68.73-25.7%
    52-week low$22.59+126.2%
    50-day average$55.32-7.6%
    200-day average$47.87+6.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 46.4%.

    MeasureValue
    1-year beta1.26
    Largest fall, 1 year-33.5%
    Largest fall, 3 years-46.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TVTX

    What is TVTX's 1-year price change?

    Travere Therapeutics's price rose 48.1% over the past 12 months. With dividends included, the 12-month total return was 48.1%.

    What is TVTX's 5-year price change?

    Travere Therapeutics's month-end price rose 74.9% over the 5 years through Oct 2026, a compound annual rate of 11.8%. These figures leave out dividends.

    What is TVTX's 52-week high and low?

    Travere Therapeutics's 52-week high is $68.73 and its 52-week low is $22.59. Its latest price of $51.10 on Nov 17, 2026 is 25.7% below the high.

    What is TVTX's beta?

    Travere Therapeutics's 1-year beta against the S&P 500 is 1.26, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 33.5%.

    Is the TVTX chart free?

    Yes. Advanced Charting for TVTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.